Teva Pharmaceutical Industries Limited (TEVJF)

Market Cap	40.20B +61.0%
Revenue (ttm)	17.26B +4.3%
Net Income	1.41B
EPS	1.21
Shares Out	n/a
PE Ratio	28.51
Forward PE	12.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130
Average Volume	425
Open	28.36
Previous Close	n/a
Day's Range	28.36 - 28.36
52-Week Range	13.73 - 32.84
Beta	0.66
RSI	63.14
Earnings Date	Jan 28, 2026

About TEVJF

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 37,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: TEVJF